goto orphan-lung-disease.netOrphan-lung-disease.net
Site Popularity:
Treatment for Highest-Risk RSV Patients | SYNAGIS® | HCP synagishcp.com
Find out more about SYNAGIS® (palivizumab) for your patients, it provides proven protection against severe RSV disease in the highest-risk infants and children.
Tags:
OrphanLungDisease
Similarity: